Zeus Sleep Ltd

Investor: National Institute for Health and Care Research (NIHR)

Zeus Sleep Ltd has successfully secured £1.48 million in funding from the National Institute for Health and Care Research (NIHR) to spearhead a large-scale multi-centre clinical trial evaluating its innovative non-invasive medical device for Obstructive Sleep Apnoea (OSA).Summary of transaction details:Value: £1.48 millionSector: Healthcare & BiotechAdvisor: Not mentionedKey Entities: Target: Zeus Sleep Ltd, Investor: National Institute for Health and Care Research (NIHR)Location: UKNote: This funding represents a critical milestone for Zeus Sleep, enabling crucial clinical validation for a device poised to offer a more accessible and adherent alternative to current Obstructive Sleep Apnoea treatments, potentially easing the burden on healthcare systems.